nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—Methotrexate—esophageal cancer	0.236	0.567	CbGbCtD
Perphenazine—CYP2C9—Capecitabine—esophageal cancer	0.0732	0.176	CbGbCtD
Perphenazine—CYP2B6—Cisplatin—esophageal cancer	0.0698	0.168	CbGbCtD
Perphenazine—CYP2C9—Cisplatin—esophageal cancer	0.0369	0.0887	CbGbCtD
Perphenazine—HTR7—vagus nerve—esophageal cancer	0.0126	0.102	CbGeAlD
Perphenazine—HTR2A—vagus nerve—esophageal cancer	0.00785	0.0639	CbGeAlD
Perphenazine—CALM2—exocrine gland—esophageal cancer	0.00444	0.0362	CbGeAlD
Perphenazine—CALM1—exocrine gland—esophageal cancer	0.00442	0.036	CbGeAlD
Perphenazine—CYP2C18—bronchus—esophageal cancer	0.00425	0.0346	CbGeAlD
Perphenazine—CYP2C18—digestive system—esophageal cancer	0.00328	0.0267	CbGeAlD
Perphenazine—Slurred speech—Cisplatin—esophageal cancer	0.00287	0.0378	CcSEcCtD
Perphenazine—CALM2—neck—esophageal cancer	0.00284	0.0231	CbGeAlD
Perphenazine—Trismus—Capecitabine—esophageal cancer	0.00283	0.0373	CcSEcCtD
Perphenazine—CALM1—neck—esophageal cancer	0.00283	0.023	CbGeAlD
Perphenazine—HTR7—neck—esophageal cancer	0.00276	0.0225	CbGeAlD
Perphenazine—AOX1—bronchus—esophageal cancer	0.00269	0.0219	CbGeAlD
Perphenazine—CALM3—bronchus—esophageal cancer	0.00242	0.0197	CbGeAlD
Perphenazine—AOX1—trachea—esophageal cancer	0.00242	0.0197	CbGeAlD
Perphenazine—CALM3—smooth muscle tissue—esophageal cancer	0.00237	0.0193	CbGeAlD
Perphenazine—Inappropriate antidiuretic hormone secretion—Cisplatin—esophageal cancer	0.00221	0.0291	CcSEcCtD
Perphenazine—Ileus paralytic—Capecitabine—esophageal cancer	0.00219	0.0288	CcSEcCtD
Perphenazine—CALM3—trachea—esophageal cancer	0.00218	0.0177	CbGeAlD
Perphenazine—AOX1—digestive system—esophageal cancer	0.00208	0.0169	CbGeAlD
Perphenazine—Retinal disorder—Methotrexate—esophageal cancer	0.00197	0.026	CcSEcCtD
Perphenazine—CALM2—epithelium—esophageal cancer	0.00193	0.0157	CbGeAlD
Perphenazine—CALM1—epithelium—esophageal cancer	0.00192	0.0157	CbGeAlD
Perphenazine—CALM2—bronchus—esophageal cancer	0.0019	0.0155	CbGeAlD
Perphenazine—CALM1—bronchus—esophageal cancer	0.00189	0.0154	CbGeAlD
Perphenazine—HTR7—epithelium—esophageal cancer	0.00188	0.0153	CbGeAlD
Perphenazine—CALM2—smooth muscle tissue—esophageal cancer	0.00186	0.0152	CbGeAlD
Perphenazine—CALM1—smooth muscle tissue—esophageal cancer	0.00185	0.0151	CbGeAlD
Perphenazine—Sudden death—Capecitabine—esophageal cancer	0.00185	0.0244	CcSEcCtD
Perphenazine—HTR7—smooth muscle tissue—esophageal cancer	0.00181	0.0147	CbGeAlD
Perphenazine—AOX1—lung—esophageal cancer	0.00174	0.0141	CbGeAlD
Perphenazine—HTR2A—neck—esophageal cancer	0.00172	0.014	CbGeAlD
Perphenazine—CALM2—trachea—esophageal cancer	0.00171	0.0139	CbGeAlD
Perphenazine—CALM1—trachea—esophageal cancer	0.0017	0.0138	CbGeAlD
Perphenazine—HTR7—trachea—esophageal cancer	0.00166	0.0135	CbGeAlD
Perphenazine—CALM3—lung—esophageal cancer	0.00156	0.0127	CbGeAlD
Perphenazine—Infection—Carboplatin—esophageal cancer	0.00155	0.0204	CcSEcCtD
Perphenazine—Liver injury—Cisplatin—esophageal cancer	0.00153	0.0201	CcSEcCtD
Perphenazine—CALM2—digestive system—esophageal cancer	0.00147	0.012	CbGeAlD
Perphenazine—CALM1—digestive system—esophageal cancer	0.00146	0.0119	CbGeAlD
Perphenazine—HTR7—digestive system—esophageal cancer	0.00143	0.0116	CbGeAlD
Perphenazine—CYP2B6—bronchus—esophageal cancer	0.00141	0.0115	CbGeAlD
Perphenazine—HRH1—epithelium—esophageal cancer	0.0014	0.0114	CbGeAlD
Perphenazine—CYP2C19—digestive system—esophageal cancer	0.0014	0.0114	CbGeAlD
Perphenazine—Sudden death—Methotrexate—esophageal cancer	0.00138	0.0181	CcSEcCtD
Perphenazine—Dysarthria—Cisplatin—esophageal cancer	0.00136	0.0179	CcSEcCtD
Perphenazine—ADRA2A—bronchus—esophageal cancer	0.00136	0.011	CbGeAlD
Perphenazine—HRH1—smooth muscle tissue—esophageal cancer	0.00135	0.011	CbGeAlD
Perphenazine—Pain—Carboplatin—esophageal cancer	0.00133	0.0176	CcSEcCtD
Perphenazine—Throat sore—Capecitabine—esophageal cancer	0.00131	0.0173	CcSEcCtD
Perphenazine—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.0013	0.0171	CcSEcCtD
Perphenazine—Hepatocellular injury—Cisplatin—esophageal cancer	0.00128	0.0169	CcSEcCtD
Perphenazine—HRH1—trachea—esophageal cancer	0.00124	0.0101	CbGeAlD
Perphenazine—Body temperature increased—Carboplatin—esophageal cancer	0.00123	0.0163	CcSEcCtD
Perphenazine—CALM2—lung—esophageal cancer	0.00123	0.00999	CbGeAlD
Perphenazine—CALM1—lung—esophageal cancer	0.00122	0.00995	CbGeAlD
Perphenazine—ADRA2A—trachea—esophageal cancer	0.00122	0.00992	CbGeAlD
Perphenazine—HTR7—lung—esophageal cancer	0.00119	0.00972	CbGeAlD
Perphenazine—AOX1—lymph node—esophageal cancer	0.00119	0.00966	CbGeAlD
Perphenazine—HTR2A—epithelium—esophageal cancer	0.00117	0.00954	CbGeAlD
Perphenazine—CYP1A2—digestive system—esophageal cancer	0.00114	0.00928	CbGeAlD
Perphenazine—HTR2A—smooth muscle tissue—esophageal cancer	0.00113	0.00919	CbGeAlD
Perphenazine—DRD2—lung—esophageal cancer	0.00113	0.00919	CbGeAlD
Perphenazine—CYP2B6—digestive system—esophageal cancer	0.00109	0.0089	CbGeAlD
Perphenazine—CYP2C9—digestive system—esophageal cancer	0.00108	0.00881	CbGeAlD
Perphenazine—CALM3—lymph node—esophageal cancer	0.00107	0.0087	CbGeAlD
Perphenazine—HRH1—digestive system—esophageal cancer	0.00107	0.00869	CbGeAlD
Perphenazine—Polyuria—Cisplatin—esophageal cancer	0.00106	0.014	CcSEcCtD
Perphenazine—Oropharyngeal pain—Capecitabine—esophageal cancer	0.00104	0.0137	CcSEcCtD
Perphenazine—HTR2A—trachea—esophageal cancer	0.00104	0.00843	CbGeAlD
Perphenazine—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00103	0.0136	CcSEcCtD
Perphenazine—Nasal congestion—Cisplatin—esophageal cancer	0.00102	0.0135	CcSEcCtD
Perphenazine—Dysarthria—Capecitabine—esophageal cancer	0.001	0.0132	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000963	0.0127	CcSEcCtD
Perphenazine—CYP1A2—lung—esophageal cancer	0.000952	0.00775	CbGeAlD
Perphenazine—CYP2B6—lung—esophageal cancer	0.000913	0.00743	CbGeAlD
Perphenazine—HTR2A—digestive system—esophageal cancer	0.000891	0.00726	CbGeAlD
Perphenazine—HRH1—lung—esophageal cancer	0.000891	0.00726	CbGeAlD
Perphenazine—ADRA2A—lung—esophageal cancer	0.000875	0.00713	CbGeAlD
Perphenazine—Urine output increased—Capecitabine—esophageal cancer	0.000855	0.0113	CcSEcCtD
Perphenazine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000851	0.0112	CcSEcCtD
Perphenazine—CALM2—lymph node—esophageal cancer	0.00084	0.00683	CbGeAlD
Perphenazine—CALM1—lymph node—esophageal cancer	0.000836	0.0068	CbGeAlD
Perphenazine—CYP3A4—digestive system—esophageal cancer	0.000825	0.00672	CbGeAlD
Perphenazine—CYP2D6—digestive system—esophageal cancer	0.000812	0.00661	CbGeAlD
Perphenazine—Polyuria—Capecitabine—esophageal cancer	0.000782	0.0103	CcSEcCtD
Perphenazine—Photosensitivity—Capecitabine—esophageal cancer	0.000782	0.0103	CcSEcCtD
Perphenazine—Pancytopenia—Cisplatin—esophageal cancer	0.000765	0.0101	CcSEcCtD
Perphenazine—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000761	0.01	CcSEcCtD
Perphenazine—Dysarthria—Methotrexate—esophageal cancer	0.000745	0.00981	CcSEcCtD
Perphenazine—HTR2A—lung—esophageal cancer	0.000744	0.00606	CbGeAlD
Perphenazine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000728	0.00959	CcSEcCtD
Perphenazine—Lethargy—Capecitabine—esophageal cancer	0.000701	0.00923	CcSEcCtD
Perphenazine—Bradycardia—Cisplatin—esophageal cancer	0.000656	0.00864	CcSEcCtD
Perphenazine—Cardiac arrest—Capecitabine—esophageal cancer	0.000653	0.0086	CcSEcCtD
Perphenazine—Urinary retention—Capecitabine—esophageal cancer	0.000653	0.0086	CcSEcCtD
Perphenazine—Ataxia—Capecitabine—esophageal cancer	0.000646	0.00851	CcSEcCtD
Perphenazine—Urine output increased—Methotrexate—esophageal cancer	0.000637	0.00839	CcSEcCtD
Perphenazine—Gynaecomastia—Methotrexate—esophageal cancer	0.00063	0.0083	CcSEcCtD
Perphenazine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000627	0.00826	CcSEcCtD
Perphenazine—HRH1—lymph node—esophageal cancer	0.00061	0.00496	CbGeAlD
Perphenazine—Muscular weakness—Capecitabine—esophageal cancer	0.000606	0.00798	CcSEcCtD
Perphenazine—ADRA2A—lymph node—esophageal cancer	0.000599	0.00487	CbGeAlD
Perphenazine—Asthma—Capecitabine—esophageal cancer	0.000594	0.00782	CcSEcCtD
Perphenazine—Dysphagia—Capecitabine—esophageal cancer	0.000594	0.00782	CcSEcCtD
Perphenazine—Polyuria—Methotrexate—esophageal cancer	0.000582	0.00767	CcSEcCtD
Perphenazine—Photosensitivity—Methotrexate—esophageal cancer	0.000582	0.00767	CcSEcCtD
Perphenazine—Pancytopenia—Capecitabine—esophageal cancer	0.000564	0.00742	CcSEcCtD
Perphenazine—Erythema—Cisplatin—esophageal cancer	0.000561	0.00739	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000542	0.00714	CcSEcCtD
Perphenazine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000542	0.00714	CcSEcCtD
Perphenazine—Muscle spasms—Cisplatin—esophageal cancer	0.000539	0.0071	CcSEcCtD
Perphenazine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000535	0.00705	CcSEcCtD
Perphenazine—Vision blurred—Cisplatin—esophageal cancer	0.000529	0.00696	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000528	0.00696	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—esophageal cancer	0.000522	0.00687	CcSEcCtD
Perphenazine—Jaundice—Capecitabine—esophageal cancer	0.000516	0.00679	CcSEcCtD
Perphenazine—Leukopenia—Cisplatin—esophageal cancer	0.000502	0.00661	CcSEcCtD
Perphenazine—Agranulocytosis—Capecitabine—esophageal cancer	0.000494	0.00651	CcSEcCtD
Perphenazine—Convulsion—Cisplatin—esophageal cancer	0.000486	0.0064	CcSEcCtD
Perphenazine—Bradycardia—Capecitabine—esophageal cancer	0.000484	0.00637	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—esophageal cancer	0.000481	0.00633	CcSEcCtD
Perphenazine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000473	0.00623	CcSEcCtD
Perphenazine—Oedema peripheral—Capecitabine—esophageal cancer	0.000468	0.00616	CcSEcCtD
Perphenazine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000458	0.00603	CcSEcCtD
Perphenazine—Infection—Cisplatin—esophageal cancer	0.000455	0.00599	CcSEcCtD
Perphenazine—Tachycardia—Cisplatin—esophageal cancer	0.000447	0.00589	CcSEcCtD
Perphenazine—Asthma—Methotrexate—esophageal cancer	0.000442	0.00582	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—esophageal cancer	0.000437	0.00576	CcSEcCtD
Perphenazine—Anorexia—Cisplatin—esophageal cancer	0.000436	0.00575	CcSEcCtD
Perphenazine—Hypotension—Cisplatin—esophageal cancer	0.000428	0.00564	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—esophageal cancer	0.00042	0.00553	CcSEcCtD
Perphenazine—Erythema—Capecitabine—esophageal cancer	0.000414	0.00545	CcSEcCtD
Perphenazine—Dyspnoea—Cisplatin—esophageal cancer	0.000408	0.00538	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000403	0.00531	CcSEcCtD
Perphenazine—Flupentixol—ABCB1—esophageal cancer	0.000398	0.16	CrCbGaD
Perphenazine—Decreased appetite—Cisplatin—esophageal cancer	0.000398	0.00524	CcSEcCtD
Perphenazine—Muscle spasms—Capecitabine—esophageal cancer	0.000398	0.00524	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—esophageal cancer	0.000394	0.00519	CcSEcCtD
Perphenazine—Pain—Cisplatin—esophageal cancer	0.000392	0.00516	CcSEcCtD
Perphenazine—Vision blurred—Capecitabine—esophageal cancer	0.00039	0.00513	CcSEcCtD
Perphenazine—Syncope—Capecitabine—esophageal cancer	0.000371	0.00489	CcSEcCtD
Perphenazine—Leukopenia—Capecitabine—esophageal cancer	0.00037	0.00488	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—esophageal cancer	0.000368	0.00484	CcSEcCtD
Perphenazine—Loss of consciousness—Capecitabine—esophageal cancer	0.000363	0.00479	CcSEcCtD
Perphenazine—Body temperature increased—Cisplatin—esophageal cancer	0.000362	0.00477	CcSEcCtD
Perphenazine—Cough—Capecitabine—esophageal cancer	0.000361	0.00475	CcSEcCtD
Perphenazine—Hypertension—Capecitabine—esophageal cancer	0.000357	0.0047	CcSEcCtD
Perphenazine—Dry mouth—Capecitabine—esophageal cancer	0.000344	0.00454	CcSEcCtD
Perphenazine—Confusional state—Capecitabine—esophageal cancer	0.00034	0.00448	CcSEcCtD
Perphenazine—Hypersensitivity—Cisplatin—esophageal cancer	0.000337	0.00444	CcSEcCtD
Perphenazine—Infection—Capecitabine—esophageal cancer	0.000335	0.00442	CcSEcCtD
Perphenazine—Shock—Capecitabine—esophageal cancer	0.000332	0.00437	CcSEcCtD
Perphenazine—Tachycardia—Capecitabine—esophageal cancer	0.000329	0.00434	CcSEcCtD
Perphenazine—Anorexia—Capecitabine—esophageal cancer	0.000322	0.00424	CcSEcCtD
Perphenazine—Hypotension—Capecitabine—esophageal cancer	0.000315	0.00415	CcSEcCtD
Perphenazine—Diarrhoea—Cisplatin—esophageal cancer	0.000313	0.00413	CcSEcCtD
Perphenazine—Erythema—Methotrexate—esophageal cancer	0.000308	0.00406	CcSEcCtD
Perphenazine—Insomnia—Capecitabine—esophageal cancer	0.000305	0.00402	CcSEcCtD
Perphenazine—Dyspnoea—Capecitabine—esophageal cancer	0.000301	0.00396	CcSEcCtD
Perphenazine—Decreased appetite—Capecitabine—esophageal cancer	0.000293	0.00386	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—esophageal cancer	0.00029	0.00382	CcSEcCtD
Perphenazine—Constipation—Capecitabine—esophageal cancer	0.000289	0.0038	CcSEcCtD
Perphenazine—Pain—Capecitabine—esophageal cancer	0.000289	0.0038	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—esophageal cancer	0.000276	0.00363	CcSEcCtD
Perphenazine—Cough—Methotrexate—esophageal cancer	0.000269	0.00354	CcSEcCtD
Perphenazine—Urticaria—Capecitabine—esophageal cancer	0.000268	0.00353	CcSEcCtD
Perphenazine—Domperidone—ABCB1—esophageal cancer	0.000268	0.108	CrCbGaD
Perphenazine—Body temperature increased—Capecitabine—esophageal cancer	0.000267	0.00351	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—esophageal cancer	0.000267	0.00351	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—esophageal cancer	0.000253	0.00334	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000251	0.00331	CcSEcCtD
Perphenazine—Infection—Methotrexate—esophageal cancer	0.00025	0.00329	CcSEcCtD
Perphenazine—Hypersensitivity—Capecitabine—esophageal cancer	0.000249	0.00328	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—esophageal cancer	0.00024	0.00315	CcSEcCtD
Perphenazine—Pruritus—Capecitabine—esophageal cancer	0.000239	0.00315	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—esophageal cancer	0.000235	0.00309	CcSEcCtD
Perphenazine—Diarrhoea—Capecitabine—esophageal cancer	0.000231	0.00304	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—esophageal cancer	0.000227	0.00299	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—esophageal cancer	0.000224	0.00295	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—esophageal cancer	0.000223	0.00294	CcSEcCtD
Perphenazine—Dizziness—Capecitabine—esophageal cancer	0.000223	0.00294	CcSEcCtD
Perphenazine—Nefazodone—ABCB1—esophageal cancer	0.000223	0.0893	CrCbGaD
Perphenazine—Decreased appetite—Methotrexate—esophageal cancer	0.000218	0.00288	CcSEcCtD
Perphenazine—Triflupromazine—ABCB1—esophageal cancer	0.000217	0.087	CrCbGaD
Perphenazine—Pain—Methotrexate—esophageal cancer	0.000215	0.00283	CcSEcCtD
Perphenazine—Headache—Capecitabine—esophageal cancer	0.000211	0.00279	CcSEcCtD
Perphenazine—Aripiprazole—ABCB1—esophageal cancer	0.000207	0.083	CrCbGaD
Perphenazine—Trazodone—ABCB1—esophageal cancer	0.000206	0.0826	CrCbGaD
Perphenazine—Urticaria—Methotrexate—esophageal cancer	0.0002	0.00263	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—esophageal cancer	0.000199	0.00262	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—esophageal cancer	0.000185	0.00244	CcSEcCtD
Perphenazine—Pruritus—Methotrexate—esophageal cancer	0.000178	0.00234	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—esophageal cancer	0.000172	0.00226	CcSEcCtD
Perphenazine—Fluphenazine—ABCB1—esophageal cancer	0.000167	0.0669	CrCbGaD
Perphenazine—Dizziness—Methotrexate—esophageal cancer	0.000166	0.00219	CcSEcCtD
Perphenazine—Headache—Methotrexate—esophageal cancer	0.000157	0.00207	CcSEcCtD
Perphenazine—Clomipramine—ABCB1—esophageal cancer	0.000153	0.0612	CrCbGaD
Perphenazine—Chlorprothixene—ABCB1—esophageal cancer	0.000152	0.0609	CrCbGaD
Perphenazine—Promethazine—ABCB1—esophageal cancer	0.000135	0.0542	CrCbGaD
Perphenazine—Trifluoperazine—ABCB1—esophageal cancer	0.000133	0.0535	CrCbGaD
Perphenazine—Quetiapine—ABCB1—esophageal cancer	0.000129	0.0519	CrCbGaD
Perphenazine—Chlorpromazine—ABCB1—esophageal cancer	0.000105	0.042	CrCbGaD
Perphenazine—HTR6—Signaling Pathways—EP300—esophageal cancer	1.19e-05	3.11e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—EP300—esophageal cancer	1.19e-05	3.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—NOS3—esophageal cancer	1.19e-05	3.1e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.19e-05	3.1e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.18e-05	3.09e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.18e-05	3.07e-05	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—PIK3CA—esophageal cancer	1.17e-05	3.05e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.17e-05	3.05e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—ERBB2—esophageal cancer	1.16e-05	3.04e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—ERBB2—esophageal cancer	1.16e-05	3.04e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NOS3—esophageal cancer	1.16e-05	3.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—PIK3CA—esophageal cancer	1.15e-05	3.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—PIK3CA—esophageal cancer	1.15e-05	3.01e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NOS3—esophageal cancer	1.15e-05	3.01e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—NOS3—esophageal cancer	1.15e-05	3e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—NOS3—esophageal cancer	1.15e-05	3e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.15e-05	3e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—CREBBP—esophageal cancer	1.14e-05	2.98e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CREBBP—esophageal cancer	1.14e-05	2.97e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HIF1A—esophageal cancer	1.14e-05	2.97e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	1.12e-05	2.93e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CREBBP—esophageal cancer	1.12e-05	2.92e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—EGFR—esophageal cancer	1.12e-05	2.92e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CREBBP—esophageal cancer	1.12e-05	2.91e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CCND1—esophageal cancer	1.11e-05	2.91e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—CREBBP—esophageal cancer	1.11e-05	2.9e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—ERBB2—esophageal cancer	1.11e-05	2.9e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.11e-05	2.89e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.11e-05	2.89e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	1.1e-05	2.88e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HIF1A—esophageal cancer	1.1e-05	2.87e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HIF1A—esophageal cancer	1.1e-05	2.87e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—EGFR—esophageal cancer	1.1e-05	2.87e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—PIK3CA—esophageal cancer	1.1e-05	2.87e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—EGFR—esophageal cancer	1.1e-05	2.86e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.09e-05	2.85e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.09e-05	2.85e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.09e-05	2.85e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—NOS3—esophageal cancer	1.09e-05	2.84e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KDR—esophageal cancer	1.09e-05	2.84e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTGS2—esophageal cancer	1.09e-05	2.83e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	1.08e-05	2.83e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—ERBB2—esophageal cancer	1.08e-05	2.82e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CDKN1A—esophageal cancer	1.08e-05	2.81e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—CREBBP—esophageal cancer	1.07e-05	2.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—CREBBP—esophageal cancer	1.07e-05	2.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—ERBB2—esophageal cancer	1.07e-05	2.8e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—ERBB2—esophageal cancer	1.07e-05	2.8e-05	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.07e-05	2.79e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KDR—esophageal cancer	1.05e-05	2.74e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KDR—esophageal cancer	1.05e-05	2.74e-05	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.05e-05	2.74e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTGS2—esophageal cancer	1.05e-05	2.74e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTGS2—esophageal cancer	1.05e-05	2.74e-05	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.05e-05	2.74e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.05e-05	2.73e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MYC—esophageal cancer	1.04e-05	2.71e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MYC—esophageal cancer	1.04e-05	2.71e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CDKN1A—esophageal cancer	1.03e-05	2.68e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.03e-05	2.68e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—EP300—esophageal cancer	1.03e-05	2.68e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NOTCH1—esophageal cancer	1.02e-05	2.67e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—NOS3—esophageal cancer	1.02e-05	2.67e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NOS3—esophageal cancer	1.02e-05	2.66e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	1.02e-05	2.66e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—EGFR—esophageal cancer	1.02e-05	2.65e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—EGFR—esophageal cancer	1.01e-05	2.65e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.01e-05	2.62e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NOS3—esophageal cancer	1e-05	2.61e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	1e-05	2.61e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NOS3—esophageal cancer	9.99e-06	2.61e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PTGS2—esophageal cancer	9.96e-06	2.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CDKN1A—esophageal cancer	9.94e-06	2.6e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CDKN1A—esophageal cancer	9.94e-06	2.6e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—NOS3—esophageal cancer	9.94e-06	2.59e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NOTCH1—esophageal cancer	9.9e-06	2.59e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NOTCH1—esophageal cancer	9.9e-06	2.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—EP300—esophageal cancer	9.78e-06	2.55e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.75e-06	2.55e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	9.69e-06	2.53e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—CREBBP—esophageal cancer	9.66e-06	2.52e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—NOS3—esophageal cancer	9.62e-06	2.51e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—NOS3—esophageal cancer	9.62e-06	2.51e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CCND1—esophageal cancer	9.58e-06	2.5e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	9.56e-06	2.49e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—PIK3CA—esophageal cancer	9.54e-06	2.49e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CCND1—esophageal cancer	9.53e-06	2.49e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—ERBB2—esophageal cancer	9.52e-06	2.48e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—PIK3CA—esophageal cancer	9.52e-06	2.48e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—CDKN1A—esophageal cancer	9.49e-06	2.48e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EP300—esophageal cancer	9.46e-06	2.47e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EP300—esophageal cancer	9.46e-06	2.47e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.42e-06	2.46e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—ERBB2—esophageal cancer	9.37e-06	2.44e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—ERBB2—esophageal cancer	9.35e-06	2.44e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTGS2—esophageal cancer	9.34e-06	2.44e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CREBBP—esophageal cancer	9.28e-06	2.42e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	9.27e-06	2.42e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CDKN1A—esophageal cancer	9.22e-06	2.41e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—CDKN1A—esophageal cancer	9.18e-06	2.4e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—CDKN1A—esophageal cancer	9.18e-06	2.4e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—EGFR—esophageal cancer	9.12e-06	2.38e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	9.11e-06	2.38e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—esophageal cancer	9.09e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EP300—esophageal cancer	9.03e-06	2.36e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CREBBP—esophageal cancer	8.98e-06	2.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CREBBP—esophageal cancer	8.98e-06	2.34e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MYC—esophageal cancer	8.93e-06	2.33e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.89e-06	2.32e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.86e-06	2.31e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—EGFR—esophageal cancer	8.82e-06	2.3e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—EGFR—esophageal cancer	8.82e-06	2.3e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EP300—esophageal cancer	8.82e-06	2.3e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—PIK3CA—esophageal cancer	8.81e-06	2.3e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—PIK3CA—esophageal cancer	8.8e-06	2.3e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—esophageal cancer	8.79e-06	2.3e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—esophageal cancer	8.79e-06	2.3e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EP300—esophageal cancer	8.77e-06	2.29e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—EGFR—esophageal cancer	8.74e-06	2.28e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EP300—esophageal cancer	8.73e-06	2.28e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EP300—esophageal cancer	8.73e-06	2.28e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	8.68e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—NOS3—esophageal cancer	8.65e-06	2.26e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CREBBP—esophageal cancer	8.62e-06	2.25e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—esophageal cancer	8.52e-06	2.22e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	8.52e-06	2.22e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—esophageal cancer	8.51e-06	2.22e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCND1—esophageal cancer	8.41e-06	2.2e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—EGFR—esophageal cancer	8.34e-06	2.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NOS3—esophageal cancer	8.31e-06	2.17e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—EP300—esophageal cancer	8.29e-06	2.16e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCND1—esophageal cancer	8.27e-06	2.16e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCND1—esophageal cancer	8.26e-06	2.16e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	8.14e-06	2.12e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.08e-06	2.11e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EGFR—esophageal cancer	8.06e-06	2.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EGFR—esophageal cancer	8.06e-06	2.1e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NOS3—esophageal cancer	8.04e-06	2.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NOS3—esophageal cancer	8.04e-06	2.1e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CDKN1A—esophageal cancer	8e-06	2.09e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CDKN1A—esophageal cancer	7.99e-06	2.08e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CREBBP—esophageal cancer	7.93e-06	2.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—PIK3CA—esophageal cancer	7.92e-06	2.07e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—esophageal cancer	7.91e-06	2.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MYC—esophageal cancer	7.87e-06	2.05e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CREBBP—esophageal cancer	7.86e-06	2.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ERBB2—esophageal cancer	7.77e-06	2.03e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—EP300—esophageal cancer	7.77e-06	2.03e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.76e-06	2.02e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EP300—esophageal cancer	7.74e-06	2.02e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—NOS3—esophageal cancer	7.72e-06	2.01e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EGFR—esophageal cancer	7.7e-06	2.01e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MYC—esophageal cancer	7.68e-06	2.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PIK3CA—esophageal cancer	7.66e-06	2e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PIK3CA—esophageal cancer	7.66e-06	2e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—esophageal cancer	7.64e-06	2e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EP300—esophageal cancer	7.62e-06	1.99e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—esophageal cancer	7.61e-06	1.99e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—esophageal cancer	7.61e-06	1.99e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EP300—esophageal cancer	7.6e-06	1.98e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.6e-06	1.98e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—esophageal cancer	7.58e-06	1.98e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—EP300—esophageal cancer	7.56e-06	1.97e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	7.53e-06	1.97e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ERBB2—esophageal cancer	7.52e-06	1.96e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ERBB2—esophageal cancer	7.52e-06	1.96e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—esophageal cancer	7.51e-06	1.96e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—esophageal cancer	7.48e-06	1.95e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—esophageal cancer	7.44e-06	1.94e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—esophageal cancer	7.44e-06	1.94e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—esophageal cancer	7.34e-06	1.92e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—EP300—esophageal cancer	7.31e-06	1.91e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—EP300—esophageal cancer	7.31e-06	1.91e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	7.28e-06	1.9e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—esophageal cancer	7.23e-06	1.89e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—NOS3—esophageal cancer	7.1e-06	1.85e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—esophageal cancer	7.06e-06	1.84e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—NOS3—esophageal cancer	7.04e-06	1.84e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—esophageal cancer	7e-06	1.83e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—esophageal cancer	7e-06	1.83e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EP300—esophageal cancer	6.93e-06	1.81e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—esophageal cancer	6.87e-06	1.79e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—esophageal cancer	6.75e-06	1.76e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.72e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—esophageal cancer	6.68e-06	1.74e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1A—esophageal cancer	6.64e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—esophageal cancer	6.64e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—esophageal cancer	6.64e-06	1.73e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—esophageal cancer	6.64e-06	1.73e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—esophageal cancer	6.62e-06	1.73e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—esophageal cancer	6.6e-06	1.72e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—EP300—esophageal cancer	6.58e-06	1.72e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	6.52e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—esophageal cancer	6.49e-06	1.69e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—esophageal cancer	6.49e-06	1.69e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—esophageal cancer	6.49e-06	1.69e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—esophageal cancer	6.48e-06	1.69e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—esophageal cancer	6.46e-06	1.69e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—esophageal cancer	6.46e-06	1.69e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—esophageal cancer	6.44e-06	1.68e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1A—esophageal cancer	6.43e-06	1.68e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1A—esophageal cancer	6.43e-06	1.68e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EP300—esophageal cancer	6.32e-06	1.65e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—esophageal cancer	6.31e-06	1.65e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—esophageal cancer	6.28e-06	1.64e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—esophageal cancer	6.13e-06	1.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EP300—esophageal cancer	6.12e-06	1.6e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EP300—esophageal cancer	6.12e-06	1.6e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—esophageal cancer	6.04e-06	1.58e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—NOS3—esophageal cancer	6.01e-06	1.57e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	5.91e-06	1.54e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—EP300—esophageal cancer	5.87e-06	1.53e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—esophageal cancer	5.75e-06	1.5e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	5.73e-06	1.49e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—esophageal cancer	5.63e-06	1.47e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—esophageal cancer	5.62e-06	1.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—esophageal cancer	5.59e-06	1.46e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—esophageal cancer	5.54e-06	1.45e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—esophageal cancer	5.51e-06	1.44e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.5e-06	1.44e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—esophageal cancer	5.45e-06	1.42e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—esophageal cancer	5.44e-06	1.42e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—esophageal cancer	5.41e-06	1.41e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—esophageal cancer	5.41e-06	1.41e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—EP300—esophageal cancer	5.4e-06	1.41e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—esophageal cancer	5.39e-06	1.41e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—EP300—esophageal cancer	5.35e-06	1.4e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—esophageal cancer	5.33e-06	1.39e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—esophageal cancer	5.33e-06	1.39e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—esophageal cancer	5.21e-06	1.36e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—esophageal cancer	5.21e-06	1.36e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.18e-06	1.35e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	5.13e-06	1.34e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—esophageal cancer	4.96e-06	1.29e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	4.87e-06	1.27e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—esophageal cancer	4.68e-06	1.22e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—NOS3—esophageal cancer	4.64e-06	1.21e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—EP300—esophageal cancer	4.57e-06	1.19e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—esophageal cancer	4.52e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—esophageal cancer	4.52e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—esophageal cancer	4.52e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—esophageal cancer	4.38e-06	1.14e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—esophageal cancer	4.38e-06	1.14e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	4.34e-06	1.13e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.25e-06	1.11e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.99e-06	1.04e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.96e-06	1.03e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—EP300—esophageal cancer	3.53e-06	9.22e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.38e-06	8.83e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.61e-06	6.82e-06	CbGpPWpGaD
